中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
合肥物质科学研究院 [3]
长春光学精密机械与物... [1]
采集方式
OAI收割 [4]
_filter
_filter
_filter
筛选
浏览/检索结果:
共4条,第1-4条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer and brain metastases (PERMEATE trial): overall survival results from a multicenter, single-arm, two-cohort, phase 2 trial
期刊论文
OAI收割
ECLINICALMEDICINE, 2024, 卷号: 76
作者:
Yan, Min
;
Ouyang, Quchang
;
Sun, Tao
;
Niu, Limin
;
Yang, Jin
  |  
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2024/11/20
Pyrotinib
Human epidermal growth factor receptor 2
Breast cancer
Brain metastases
Overall survival
The reversal of anti-HER2 resistance in advanced HER2-positive breast cancer using apatinib: two cases reports and literature review
期刊论文
OAI收割
TRANSLATIONAL CANCER RESEARCH, 2022
作者:
He, Libin
;
Shen, Xiabo
;
Liu, Yiyuan
;
Gao, Lu
;
Wu, Jiayi
  |  
收藏
  |  
浏览/下载:42/0
  |  
提交时间:2022/12/23
Advanced human epidermal growth factor receptor 2-positive breast cancer (advanced HER2-positive breast cancer)
apatinib
case report
Risk evaluation of early-stage hormone receptor-positive and human epidermal growth factor receptor 2-negative breast cancer patients: a population-based study from Taiwan
期刊论文
OAI收割
BREAST CANCER RESEARCH AND TREATMENT, 2021
作者:
Lei, Lei
;
Chan, Han-Ching
;
Lu, Tzu-Pin
;
Cheng, Skye Hung-Chun
  |  
收藏
  |  
浏览/下载:38/0
  |  
提交时间:2021/08/30
Human epidermal growth factor receptor 2
Breast cancer
Dutch criteria
Taiwan
EGFR-specific CAR-T cells trigger cell lysis in EGFR-positive TNBC
期刊论文
OAI收割
Aging-Us, 2019, 卷号: 11, 期号: 23, 页码: 11054-11072
作者:
Y.Liu
;
Y.H.Zhou
;
K.H.Huang
;
Y.Li
;
X.J.Fang
  |  
收藏
  |  
浏览/下载:59/0
  |  
提交时间:2020/08/24
triple-negative breast cancer,human epidermal growth factor receptor,chimeric antigen receptor engineered T cells,negative breast-cancer,growth-factor receptor,therapy,amplification,inhibition,expression,challenges,mutations,her2,Cell Biology,Geriatrics & Gerontology